Physician profile
Kellie Reed
NPI 1285993535
$11,414.33
in general payments reported to CMS, 2019-2025
37 companies · $2,886 in 2025
The $2,886 reported for 2025 was more than what 84% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,117 · 2020: $264 · 2021: $694 · 2022: $1,991 · 2023: $1,487 · 2024: $1,974 · 2025: $2,886.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,275 · Education: $72.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,275.48 |
| Education | $72.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,324.14 | 2019-2025 | |
| Galderma Laboratories, L.P. | $1,259.78 | 2019-2025 | Aklief, Nemluvio, Oracea |
| Janssen Biotech, INC. | $1,128.19 | 2019-2025 | Tremfya, Simponi, Simponi Aria |
| Ucb, INC. | $685.09 | 2019-2025 | Bimzelx, Cimzia |
| Merz North America, INC. | $606.46 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $581.23 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $414.73 | 2019-2025 | Dupixent, Libtayo |
| Allergan, INC. | $361.77 | 2019-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $324.09 | 2019-2025 | Cabtreo, Arazlo, Jublia |
| Genzyme Corporation | $320.82 | 2019-2025 | |
| Incyte Corporation | $316.28 | 2022-2025 | Opzelura |
| Leo Pharma INC. | $304.76 | 2019-2025 | Adbry |
| Arcutis Biotherapeutics, INC. | $293.50 | 2023-2025 | Zoryve |
| Pfizer INC. | $246.69 | 2019-2024 | |
| Lilly USA, LLC | $211.09 | 2019-2025 | Taltz, Ebglyss, Olumiant |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kellie Reed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.